6322 Federal Register / Vol. 86, No. 12 / Thursday, January 21, 2021 / Notices 

To request accommodation of a 

disability, please contact Tom Tracy at 

least ten days prior to the meeting to 

give the EPA adequate time to process 

your request. 

(Authority: Pub. L. 92–463, 1, Oct. 6, 1972, 

86 Stat. 770) 

Mary Ross, 

Director, Office of Science Advisor, Policy 

and Engagement. 

[FR Doc. 2021–01206 Filed 1–19–21; 8:45 am] 

BILLING CODE 6560–50–P 

ENVIRONMENTAL PROTECTION 

AGENCY 

[EPA–HQ–OPPT–2018–0604; FRL–10017– 

50] 

C.I. Pigment Violet 29; Final Toxic 

Substances Control Act (TSCA) Risk 

Evaluation; Notice of Availability 

AGENCY: Environmental Protection 

Agency (EPA). 

ACTION: Notice. 

SUMMARY: The Environmental Protection 

Agency (EPA) is announcing the 

availability of the final Toxic 

Substances Control Act (TSCA) risk 

evaluation of C.I. Pigment Violet 29. The 

purpose of conducting risk evaluations 

under TSCA is to determine whether a 

chemical substance presents an 

unreasonable risk of injury to health or 

the environment under the conditions of 

use, including an unreasonable risk to a 

relevant potentially exposed or 

susceptible subpopulation, without 

consideration of costs or other nonrisk 

factors. EPA has determined that 

specific conditions of use of C.I. 

Pigment Violet 29 present an 

unreasonable risk of injury to health or 

the environment. For those conditions 

of use for which EPA has found an 

unreasonable risk, EPA must move to 

address that unreasonable risk through 

risk management measures enumerated 

in TSCA. EPA has also determined that 

specific conditions of use do not present 

unreasonable risk of injury to health or 

the environment. For those conditions 

of use for which EPA has found no 

unreasonable risk to health or the 

environment, the Agency’s 

determination is a final Agency action 

and is issued via order in the risk 

evaluation. 

ADDRESSES: The docket for this action, 

identified by docket identification (ID) 

number EPA–HQ–OPPT–2018–0604, is 

available online at http://

www.regulations.gov or in-person at the 

Office of Pollution Prevention and 

Toxics Docket (OPPT Docket), 

Environmental Protection Agency 

Docket Center (EPA/DC), West William 

Jefferson Clinton Bldg., Rm. 3334, 1301 

Constitution Ave. NW, Washington, DC. 

The Public Reading Room is open from 

8:30 a.m. to 4:30 p.m., Monday through 

Friday, excluding legal holidays. The 

telephone number for the Public 

Reading Room is (202) 566–1744, and 

the telephone number for the OPPT 

Docket is (202) 566–0280. Please review 

the visitor instructions and additional 

information about the docket available 

at http://www.epa.gov/dockets. 

Due to the public health concerns 

related to COVID–19, the EPA Docket 

Center (EPA/DC) and Reading Room is 

closed to visitors with limited 

exceptions. The staff continues to 

provide remote customer service via 

email, phone, and webform. For the 

latest status information on EPA/DC 

services and docket access, visit https:// 

www.epa.gov/dockets. 

FOR FURTHER INFORMATION CONTACT: 

For technical information contact: 

Seema Schappelle, Office of Pollution 

Prevention and Toxics, Environmental 

Protection Agency, 1200 Pennsylvania 

Ave. NW, Washington, DC 20460–0001; 

telephone number: (202) 564–8006; 

email address: schappelle.seema@

epa.gov. 

For general information contact: The 

TSCA-Hotline, ABVI-Goodwill, 422 

South Clinton Ave., Rochester, NY 

14620; telephone number: (202) 554– 

1404; email address: TSCA-Hotline@

epa.gov. 

SUPPLEMENTARY INFORMATION: 

I. General Information 

A. Does this action apply to me? 

This action is directed to the public 

in general. This action may be of 

interest to persons who are or may be 

interested in risk evaluations of 

chemical substances under TSCA, 15 

U.S.C. 2601 et seq. Since other entities 

may also be interested in this final risk 

evaluation, the EPA has not attempted 

to describe all the specific entities that 

may be affected by this action. 

B. What is the Agency’s authority for 

taking this action? 

TSCA section 6, 15 U.S.C. 2605, 

requires EPA to conduct risk 

evaluations to ‘‘determine whether a 

chemical substance presents an 

unreasonable risk of injury to health or 

the environment, without consideration 

of costs or other nonrisk factors, 

including an unreasonable risk to a 

potentially exposed or susceptible 

subpopulation identified as relevant to 

the risk evaluation by the 

Administrator, under the conditions of 

use.’’ 15 U.S.C. 2605(b)(4)(A). TSCA 

sections 6(b)(4)(A) through (H) 

enumerate the deadlines and minimum 

requirements applicable to this process, 

including provisions that provide 

instruction on chemical substances that 

must undergo evaluation, the minimum 

components of a TSCA risk evaluation, 

and the timelines for public comment 

and completion of the risk evaluation. 

TSCA also requires that EPA operate in 

a manner that is consistent with the best 

available science, make decisions based 

on the weight of the scientific evidence 

and consider reasonably available 

information. 15 U.S.C. 2625(h), (i), and 

(k). TSCA section 6(i) directs that a 

determination of ‘‘no unreasonable risk’’ 

shall be issued by order and considered 

to be a final Agency action, while a 

determination of ‘‘unreasonable risk’’ is 

not considered to be a final Agency 

action. 15 U.S.C. 2605(i). 

The statute identifies the minimum 

components for all chemical substance 

risk evaluations. For each risk 

evaluation, EPA must publish a 

document that outlines the scope of the 

risk evaluation to be conducted, which 

includes the hazards, exposures, 

conditions of use, and the potentially 

exposed or susceptible subpopulations 

that EPA expects to consider. 15 U.S.C. 

2605(b)(4)(D). The statute further 

provides that each risk evaluation must 

also: (1) Integrate and assess available 

information on hazards and exposures 

for the conditions of use of the chemical 

substance, including information that is 

relevant to specific risks of injury to 

health or the environment and 

information on relevant potentially 

exposed or susceptible subpopulations; 

(2) describe whether aggregate or 

sentinel exposures were considered and 

the basis for that consideration; (3) take 

into account, where relevant, the likely 

duration, intensity, frequency, and 

number of exposures under the 

conditions of use; and (4) describe the 

weight of the scientific evidence for the 

identified hazards and exposures. 15 

U.S.C. 2605(b)(4)(F)(i) through (ii) and 

(iv) through (v). Each risk evaluation 

must not consider costs or other nonrisk 

factors. 15 U.S.C. 2605(b)(4)(F)(iii). 

The statute requires that the risk 

evaluation process be completed within 

a specified timeframe and provide an 

opportunity for public comment on a 

draft risk evaluation prior to publishing 

a final risk evaluation. 15 U.S.C. 

2605(b)(4). 

Subsection 5.4.1 of the final risk 

evaluation for C.I. Pigment Violet 29 

constitutes the order required under 

TSCA section 6(i)(1), and the ‘‘no 

unreasonable risk’’ determinations in 

that subsection are considered to be a 

final Agency action effective on the date 


jbell on DSKJLSW7X2PROD with NOTICES
Federal Register / Vol. 86, No. 12 / Thursday, January 21, 2021 / Notices 6323 

of issuance of the order. In conducting 

risk evaluations, ‘‘EPA will determine 

whether the chemical substance 

presents an unreasonable risk of injury 

to health or the environment under each 

condition of use within the scope of the 

risk evaluation . . . .’’ 40 CFR 702.47. 

Under EPA’s implementing regulations, 

‘‘[a] determination by EPA that the 

chemical substance, under one or more 

of the conditions of use within the 

scope of the risk evaluation, does not 

present an unreasonable risk of injury to 

health or the environment will be issued 

by order and considered to be a final 

Agency action, effective on the date of 

issuance of the order.’’ 40 CFR 

702.49(d). For purposes of TSCA section 

19(a)(1)(A), the date of issuance of the 

TSCA section 6(i)(1) order for C.I. 

Pigment Violet 29 shall be at 1:00 p.m. 

Eastern time (standard or daylight, as 

appropriate) on the date that is two 

weeks after the date when this notice is 

published in the Federal Register, 

which is in accordance with 40 CFR 

23.5. 

C. What action is EPA taking? 

EPA is announcing the availability of 

the risk evaluation of the chemical 

substance identified in Unit II. In this 

risk evaluation EPA has made 

unreasonable risk determinations on 

some of the conditions of use within the 

scope of the risk evaluation for this 

chemical. For those conditions of use 

for which EPA has found an 

unreasonable risk of injury to health or 

the environment, EPA must initiate 

regulatory action to address those risks 

through risk management measures 

enumerated in 15 U.S.C. 2605(a). 

EPA also is announcing the 

availability of the information required 

to be provided publicly with each risk 

evaluation, which is available online at 

http://www.regulations.gov in the 

dockets identified. 40 CFR 702.51. 

Specifically, EPA has provided: 

• The scope document and problem 

formulation (in Docket ID No. EPA–HQ– 

OPPT–2016–0725); 

• Draft risk evaluation, revised draft 

risk evaluation and final risk evaluation 

(in Docket ID No. EPA–HQ–OPPT– 

2018–0604); 

• All notices, determinations, 

findings, consent agreements, and 

orders (in Docket ID No. EPA–HQ– 

OPPT–2018–0604); 

• Any information required to be 

provided to the Agency under 15 U.S.C. 

2603 (in Docket ID No. EPA–HQ–OPPT– 

2016–0725 and Docket ID No. EPA–HQ– 

OPPT–2018–0604); 

• A nontechnical summary of the risk 

evaluation (in Docket ID No. EPA–HQ– 

OPPT–2018–0604); 

• A list of the studies, with the results 

of the studies, considered in carrying 

out each risk evaluation (Risk 

Evaluation for C.I. Pigment Violet 29) in 

Docket ID No. EPA–HQ–OPPT–2018– 

0604); 

• The final peer review report, 

including the response to peer review 

and public comments received during 

peer review (in Docket ID No. EPA–HQ– 

OPPT–2018–0604); and 

• Response to public comments 

received on the draft scope, the draft 

risk evaluation and revised draft risk 

evaluation (in Docket ID No. EPA–HQ– 

OPPT–2018–0604). 

II. TSCA Risk Evaluation 

A. What is EPA’s risk evaluation process 

for existing chemicals under TSCA? 

The risk evaluation process is the 

second step in EPA’s existing chemical 

process under TSCA, following 

prioritization and before risk 

management. As this chemical is one of 

the first ten chemical substances 

undergoing risk evaluation, the 

chemical substance was not required to 

go through prioritization (81 FR 91927, 

December 19, 2016) (FRL–9956–47). The 

purpose of conducting risk evaluations 

is to determine whether a chemical 

substance presents an unreasonable risk 

of injury to health or the environment 

under the conditions of use, including 

an unreasonable risk to a relevant 

potentially exposed or susceptible 

subpopulation. As part of this process, 

EPA must evaluate both hazard and 

exposure, not consider costs or other 

nonrisk factors, use reasonably available 

information and approaches in a 

manner that is consistent with the 

requirements in TSCA for the use of the 

best available science, and ensure 

decisions are based on the weight of the 

scientific evidence. 

The specific risk evaluation process 

that EPA has established by rule to 

implement the statutory process is set 

out in 40 CFR part 702 and summarized 

on EPA’s website at http://

www.epa.gov/assessing-and-managingchemicals-under-tsca/risk-evaluationsexisting-chemicals-under-tsca. As 

explained in the preamble to EPA’s final 

rule on procedures for risk evaluation 

(82 FR 33726, July 20, 2017) (FRL– 

9964–38), the specific regulatory 

process set out in 40 CFR part 702, 

subpart B will be followed for the first 

ten chemical substances undergoing risk 

evaluation to the maximum extent 

practicable. 

Prior to the publication of this final 

risk evaluation, a draft risk evaluation 

and a revised draft risk evaluation were 

subject to peer review and public 

comment. EPA reviewed the peer 

review reports from the Science 

Advisory Committee on Chemicals 

(SACC), a Letter Peer Review, and 

public comments and has supplemented 

the risk evaluation in response to these 

comments as appropriate. Prior to the 

publication of the draft risk evaluation, 

EPA made available the scope and 

problem formulation, and solicited 

public input on uses and exposure. 

EPA’s documents, the peer review 

report, and the public comments are in 

Docket EPA–HQ–OPPT–2018–0604 at 

http://www.regulations.gov. 

Additionally, information about the 

scope, problem formulation, and draft 

risk evaluation phases of the TSCA risk 

evaluation for this chemical is available 

at https://www.epa.gov/assessing-andmanaging-chemicals-under-tsca/riskevaluation-pigment-violet-29-anthra219- 

def6510. 

B. What is C.I. Pigment Violet 29? 

C.I. Pigment Violet 29 (Anthra[2,1,9- 

def:6,5,10-d′e′f′] diisoquinoline1,3,8,10(2H,9H)-tetrone) is a perylene 

derivative used to color materials and as 

an intermediate for other perylene 

pigments. C.I. Pigment Violet 29 is 

currently manufactured (including 

imported), processed, distributed, used, 

and disposed of as part of industrial, 

commercial, and consumer conditions 

of use. Leading applications for C.I. 

Pigment Violet 29 include use as an 

intermediate to create or adjust color of 

other perylene pigments, incorporation 

into paints and coatings used primarily 

in the automobile industry, 

incorporation into plastic and rubber 

products used primarily in automobiles 

and industrial carpeting, use in 

merchant ink for commercial printing, 

and use in consumer watercolors and 

artistic color. 

Authority: 15 U.S.C. 2601 et seq. 

Andrew Wheeler, 

Administrator. 

[FR Doc. 2021–01229 Filed 1–19–21; 8:45 am] 

BILLING CODE 6560–50–P 

ENVIRONMENTAL PROTECTION 

AGENCY 

[EPA–HQ–ORD–2015–0365; FRL–10018–32– 

ORD] 

Board of Scientific Counselors (BOSC) 

Air and Energy Subcommittee 

Meeting—February 2021 

AGENCY: Environmental Protection 

Agency (EPA). 

ACTION: Notice of public meeting. 


jbell on DSKJLSW7X2PROD with NOTICES